Leishmaniasis is a neglected vector-borne tropical infection considered to be a disease of the poor. Concentrated in poverty-stricken countries within Southeast Asia, East Africa, and Latin America, it is also endemic in several Mediterranean countries. The management of the heterogeneous syndromes determined by parasites belonging to the genus Leishmania is particularly difficult in developed, non-endemic countries owing to the unfamiliarity of physicians with clinical symptoms, diagnostic possibilities, and available treatment options. Therefore, travelers and other people who may be exposed to sand flies in endemic areas should receive counseling regarding leishmaniasis and appropriate protective measures. Serological diagnosis is rarely used for cutaneous and mucocutaneous diseases, but it is the most commonly used technique for visceral leishmaniasis. The drugs used to treat this last disease are expensive and sometimes have toxic side effects. This review highlights the diagnostic, chemotherapeutic, and immunizing strategies to control leishmaniasis, though no human vaccine is commercially available currently owing to the complexity of the cellular immune response to this parasite.

Recent updates and perspectives on leishmaniasis

Savoia, Dianella
2015-01-01

Abstract

Leishmaniasis is a neglected vector-borne tropical infection considered to be a disease of the poor. Concentrated in poverty-stricken countries within Southeast Asia, East Africa, and Latin America, it is also endemic in several Mediterranean countries. The management of the heterogeneous syndromes determined by parasites belonging to the genus Leishmania is particularly difficult in developed, non-endemic countries owing to the unfamiliarity of physicians with clinical symptoms, diagnostic possibilities, and available treatment options. Therefore, travelers and other people who may be exposed to sand flies in endemic areas should receive counseling regarding leishmaniasis and appropriate protective measures. Serological diagnosis is rarely used for cutaneous and mucocutaneous diseases, but it is the most commonly used technique for visceral leishmaniasis. The drugs used to treat this last disease are expensive and sometimes have toxic side effects. This review highlights the diagnostic, chemotherapeutic, and immunizing strategies to control leishmaniasis, though no human vaccine is commercially available currently owing to the complexity of the cellular immune response to this parasite.
2015
9
6
588
596
http://www.jidc.org/index.php/journal/article/download/6833/1317
Diagnosis; Immunotherapy; Leishmaniasis; Treatment; Africa, Eastern; Animals; Antiprotozoal Agents; Asia, Southeastern; Developing Countries; Diagnostic Tests, Routine; Humans; Latin America; Leishmania; Leishmaniasis; Mediterranean Region; Psychodidae; Insect Vectors; Parasitology; Microbiology; Infectious Diseases; Virology
Savoia, Dianella*
File in questo prodotto:
File Dimensione Formato  
Savoia et al. 2015.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 334.87 kB
Formato Adobe PDF
334.87 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1701890
Citazioni
  • ???jsp.display-item.citation.pmc??? 43
  • Scopus 119
  • ???jsp.display-item.citation.isi??? 100
social impact